Significant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report
Authors:
- Laurence AllainLALaurence Allain
- Sarah ElbazSESarah Elbaz
- Sayanthen SathyakumarSSSayanthen Sathyakumar
- William Le GallouWGWilliam Le Gallou
- Christina ColemanCCChristina Coleman
- Hallie ColtinHCHallie Coltin
- Dardye EugèneDEDardye Eugène
- Abha GuptaAGAbha Gupta
- Sebastiano A. G. LavaSebastiano A. G. Lava
- Samuele RenziSRSamuele Renzi
Open Access
Abstract
A 9-year-old boy presented with edema of the left cheek. He was diagnosed with a large aneurysmal bone cyst of the mandibular bone. Off-label treatment with denosumab for 17 months resulted in a significant reduction in the lesion. Five months after discontinuing denosumab, the patient developed severe rebound hypercalcemia and acute kidney injury, which resolved with corticosteroids. Two years after treatment discontinuation, the lesion continues to decrease in size. This case highlights the efficacy of denosumab as an off-label treatment for aneurysmal bone cysts, though it can be associated with hypercalcemia and acute kidney injury. We conclude that the use of denosumab should be considered on a case-by-case basis, with regular monitoring for side effects.Keywords
This publication has 33 references indexed in Scilit:
- Update on aneurysmal bone cyst: pathophysiology, histology, imaging and treatmentPediatric Radiology, 2022
- Denosumab in the management of Aneurysmal bone cystJoint Bone Spine, 2022
- Hypercalcemia following discontinuation of denosumab therapy: A systematic reviewBone Reports, 2021
- Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?World Journal of Pediatrics, 2020
- Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: Case report and brief literature reviewBone, 2019
- Denosumab treatment in aneurysmal bone cyst: Evaluation of nine casesPediatric Blood & Cancer, 2017
- Severe hypercalcemia following denosumab treatment in a juvenile patientJournal of Bone and Mineral Metabolism, 2015
- Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bonePediatric Blood & Cancer, 2015
- Denosumab treatment for fibrous dysplasiaJournal of Bone and Mineral Research, 2012
- Aneurysmal bone cyst. A clinicopathologic study of 238 casesCancer, 1992